Session Details
[29P]Testing, property and stability of medicinal formulation,Novel formulations/Development of novel medicines and formulations/Dispensing, prescription audit and ordering,Drug management,Risk management/Formulation testing・In-house formulation・Management of intravenous and enteral nutrition/Others
Sat. Mar 29, 2025 8:30 AM - 3:00 PM JST
Sat. Mar 29, 2025 11:30 PM - 6:00 AM UTC
Sat. Mar 29, 2025 11:30 PM - 6:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])
[29PA-320]Release Test for Preparations for Cutaneous Application: Considerations of Suitability of Test Methods According to Formulation Characteristics
○Kiichi Nonoue1, Tsuyoshi Paku1, Eiji Nakao1, Hideo Oya1 (1. Maruho Co., Ltd.)
[29PB-321]Evaluation of Factors Affecting Differences in Spray Characteristics Between Original and Generic Nasal Spray Drugs in Japan
○Tokio Morita1, Hiroyuki Yoshida1, Naomi Tomita1, Tamaki Miyazaki1, Yoji Sato1 (1. NIHS)
[29PA-322]Study on absolute determination of trifluoroacetic acid (TFA) as a residual solvent in pharmaceuticals using 19F-qNMR
○Nahoko UCHIYAMA1, Junko Hosoe1, Kohei Kiyota2, Kyoko Ishizuki1, Naoki Sugimoto1, Tatsuo Koide1, Seiji Tanaka1, Naoko Masumoto1, Michiho Ito1, Mika Murabayashi3, Taeko Shinozaki4, Yoshinori Fujimine5, Katsuya Ofuji6, Hitoshi Shimizu6, Kazuhiro Fujita6, Takashi Hasebe7, Yumi Asai7, Eri Ena7, Yoshinobu Makino8, Yasuhiro Muto9, Shinya Takaoka9, Takahiro Nakayama9, Katsuo Asakura10, Takako Suematsu10, Hitomi Abe10, Ai Kohama11, Takashi Goto12, Masu Yasuda12, Hiroaki Suwa13, Rei Watanabe13, Hitomi Okada14, Yukihiro Goda1 (1. NIHS, 2. Shionogi & Co., Ltd., 3. Takeda Pharmaceutical Co., Ltd., 4. Daiichi Sankyo Co., Ltd., 5. Otsuka Pharmaceutical Co., Ltd., 6. Chugai Pharmaceutical Co., Ltd., 7. Eisai Co., Ltd., 8. Juzen Chemical Corp., 9. FUJIFILM Wako Pure Chemical Corporation, 10. JEOL Ltd., 11. PMRJ, 12. Nippon Shinyaku Co., Ltd., 13. Sawai Pharmaceutical Co., Ltd., 14. Astellas Pharma Inc.)
[29PB-323]Oilgel using egg yolk lecithin and its application
○Yohei Amano1, Tomonori Uchida1, Toshihide Sato1 (1. Kewpie Corporation)
[29PA-324]Development of a Topical Thin Film Drug Delivery System Using Dialdehyde Cellulose
○Tanpong Chaiwarit1, Pensak Jantrawut1,2, Kanokpon Chompusri1, Papawee Srisanong1 (1. Deparment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, 2. Center of Excellence in Agro Bio-Circular-Green Industry (Agro BCG), Chiang Mai University)
[29PB-325]Quality Attributes and Technical Challenges in the Evaluation of Lipid Nanoparticle Formulations
○Yasuhiro Abe1, Akiko Usui1, Yuki Takechi-Haraya1, Hiroyuki Yoshida1, Yoji Sato1 (1. NIHS)
[29PA-326]Investigation of the usefulness of aerodynamic particle size evaluation using a pharyngeal model
○Hiroyuki Yoshida1, Tokio Morita1, Aoi Inagaki1, Naomi Tomita1, Yoji Sato1 (1. NIHS)
[29PB-327]Evaluation study of physical pharmacy for febuxostat tablet
○Kenta Mizoi1, Yuya Osaka1, Kohei Fujita1, Hiroya Miura1 (1. IUHW)
[29PA-328]Quantitative analysis of active pharmaceutical ingredients in soft capsules using Transmission Raman spectroscopy
○Keishi Yamashita1, Takahiro Komori1, Hiroshi Hisada2, Koichi Ito3, Toshiro Fukami3 (1. HORIBA TECHNO SERVICE, 2. Tekanalysis, 3. Meiji Pharmaceutical University)
[29PB-329S]Analysis of intermolecular interaction in amino acid-indomethacin co-amorphous by X-ray absorption fine structure spectroscopy and computational method
○Haruto Kobayashi1, Hironori Suzuki1, Takeshi Yoshikawa1, Syunsuke Yoshii1, Yuka Kurihara1, Syuuji Noguchi1 (1. Toho University. Faculty of Pharmaceutical Sciences)
[29PA-330S]Assessment of the Formulation Quality of Folic Acid-Containing Supplements
○Shiori Mimuro1, Yushi Kojima1,2, Koki Takeda1, Asako Nishimura1, Nobuhito Shibata1 (1. Doshisha Women's College of Liberal Arts, 2. Fizz-DI)
[29PB-331]Drugs skin penetration using a bi-continuous microemulsion containing isopropyl myristate and decanoic acid
○Kohsuke Shibasaki1, Natsumi Kameyama1, Yui Morioka1, Ryuichiro Mochizuki1, Kaname Hashizaki1, Makiko Fujii1, Hiroyuki Taguchi1 (1. School of Pharmacy, Nihon University)
[29PA-332]Study on the development of a novel boron drug using styrene-maleic acid copolymers for neutron capture therapy
○Kengo Banshoya1,2, Makoto Shirakawa3, Aoi Machida2, Haruna Uto1, Miyu Otsubo1, Hiyori Kuroki1, Yoshiharu Kaneo 1,2, Tetsuro Tanaka 1,2, Masatoshi Ohnishi 1,2 (1. Fac. Pharm. Sci., Fukuyama Univ., 2. Grad. Sch. Pharm. Sci., Fukuyama Univ., 3. Neutron Therapy Research Center, Okayama Univ.)
[29PB-333S]Disintegration test of prescription drugs andOTC drugs with various drinks.
○Yuya Sasaki1, Michiko Inuma1, Toshio Teramura1 (1. Aomori Univ., Fac. of Pharm. Sci.)
[29PA-334]A solution that improves the poor soluble API dissolution, by using porous calcium silicate FLORITE
○Koh Konishi1, Yuka Okada1, Marie Yamagata1, Ariumi Kawamoto1 (1. Tomita Pharmaceutical)
[29PB-335S]-MacTrigger-genetically engineered macrophage capable of disrupting immunosuppression of tumor and its utilization
○Toma Yoshimi1, Yusuke Hamabe1, Kenta Tanito1, Shoichi Hijii1, Kanae Wakuya1, Akihiro Kishimura1,2, Takeshi Mori1,2, Teruki Nii1,2, Yoshiki Katayama1,2 (1. Grad. Sch. Syst. Life Sci. Kyushu Univ., 2. Grad. Sch. Eng. Kyushu Univ.)
[29PA-336S]Evaluation of the effect of medication-assisting foods on the bitter taste masking and dissolution of prednisolone
○Haruka Watarai1, Kyoko Nakajima1, Kana Harada2, Yoshiaki Fujita2, Akihiro Nakamura2, Tsutomu Harada2 (1. Pharm.,Showa Univ., 2. Grad. Sch. Pharm. Sci., Showa Univ.)
[29PB-337S]Investigation of oral preparation that is expected to improve medication administration:Preparation and evaluation of tablet using ι-Carrageenan Part 2
○Sakura Kumakawa1, Ikumi Ito1 (1. Fac. Pharm. Sci., Teikyo Heisei Univ.)
[29PA-338]Mechanism investigation of preventive effect of 7-Phenylheptanoic acid on progression of chronic kidney disease in a mouse model
○Masahiro Tokuno1, Kindness Lomotey Commey1, Asami Yamamoto1, Maho Tokushige1, Kenji Tsukigawa1,2, Koji Nishi1,2, Masaki Otagiri1,2, Keishi Yamasaki1,2 (1. Fac. Pharm. Sci., Sojo Univ., 2. DDS Res. Inst,. Sojo Univ.)
[29PB-339]Evaluation of improving efficiency of return operations by TABSORT.
○Kohei Takahashi1, Yusuke Masuda1, Sho Ishida1, Kazuyuki Tanaka1, Atsushi Watanabe1 (1. Hiroshima City Hiroshima Citizens Hospital Department of Pharmacy)
[29PA-340]Impact on medical safety of the PROOFIT 1D II single-package audit support system
○Ryo Wada1, Yusuke Nakano1, Kanako Hashimoto1, Hisako Suyama1, Kayo Matuura1 (1. Omi Medical Center pharmaceutical department)
[29PB-341]Onset time analysis of rhabdomyolysis associated with SSRI and SNRI using the JADER database
○Katsuhiro Ohyama1, Yuto Okuhara1, Nonoka Abe1, Kouji Okada2,3, Yusuke Hori1 (1. Tokyo University of Pharmacy and Lifesciences, 2. Tohoku Medical and Pharmaceutical University, 3. Tohoku Medical and Pharmaceutical University Hospital)
[29PA-342]A Study on Patient Outcome Provided by Inquiries to Prescriptions Based on Clinical Laboratory Values for Kidney Function
○Ayaka Tanaka1, Satoko Arai1, Singo Tabata1, Akio Murakami1, Yosiaki Ara1 (1. National Hospital Organization Disaster Medical Center)
[29PA-343S]Experiment study about how to fill container with medicine for compounding equal volume mixture of Steroid ointment/crem and Hirudiod® soft ointment using planetary centrifugal mixer
○Honoka Inoue1, Anna Kiyomi1, Kensuke Yoshida1, Munetoshi Sugiura1, Haruka Manabe2, Ｍika Matsumoto3, Michiteru Ohtani3, Taro Ikuta4 (1. Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2. Department of Hospital Pharmacy, Tokyo Teishin Hospital, 3. Department of Hospital Pharmacy, Kyoundo Hospital, 4. Thinky Corporation)
[29PA-344]Protocol based pharmacists’ prescribing support in small and medium-sized hospitals
○ayumu hirata1, chieko yamasaki1, takehiro komiyama1, hiroki okazaki1, shizu maeda1, yukako sekita1, maho ogawa2, atsushi takano2 (1. Department of Pharmacy, Tonan Hospital, 2. Department of Surgery, Tonan Hospital)
[29PB-345]Efforts to Obtain an Antimicrobial Appropriate Use System at the National Center for Global Health and Medicine Hospital
○Ryoji Jimbo1, Hirotake Ohashi1, Suzuna Kimura1, Reiko Matsui1, Kei Yamamoto2, Takahiro Nishimura1 (1. Department of pharmacy, National Center for Global Health and Medicine, 2. Center for International Infectious Diseases, National Center for Global Health and Medicine Hospital)
[29PA-346]Results of a survey on the use of ethical drug barcodes in medical institutions.
○Kentaro Mori1, Hiroyasu Sato2, Ryohkan Funakoshi1,3 (1. Kameda General Hospital, 2. Abashiri Kosei General Hospital, 3. Medical Management Headquarters, Medical Corporation Tesshokai)
[29PB-347]Study of Storage Stability of Halved Suvorexant Tablets
○Takanori Nakajima1, Natsumi Nakatsukasa1, Ryusei Sato1, Misuzu Ota2, Yusuke Takizawa1, Takuro Kurita1 (1. Nihon Pharmaceutical University, 2. Int. Univ. of Health and Welfare, Mita Hosp.)
[29PA-348S]Efficacy and safety of scopolamine ointment applied to the skin over the salivary glands in rats
○Mutsumi Urayama1, Koichi Takagaki1, Natsuko Ishida1, Tsutomu Shimada1, Yukio Suga1, Junko Ishizaki1, Ryo Matsushita1 (1. Grad. Sch. Pharm. Sci., Kanazawa Univ.)
[29PB-349S]Formulation design and evaluation of dissolution profile of Indomethacin Sprays for Oro-mucosal Application
○Ayaka Yukawa1, Shunsuke Matsukawa2, Noriko Hida2, Momo Kenji2, Takeshi Uchikura2, Taigi Yamazaki2, Iori Taki2, Yoshiaki Fujita2, Akihiro Nakamura2, Tsutomu Harada2 (1. Pharm.,Showa Univ., 2. Grad. Sch. Pharm. Sci., Showa Univ.)
[29PA-350]Study of Therapeutic Safety and Health Care Economy Effect of Biosimilar Bevacizumab
○Naohiro Ohara1, Yohei Ikeue1, Hiromi Sekimoto2,3, Yoshihisa Honda2,4, Toshiaki Fukuda1 (1. Kyoto Medical Center Pharmacy Department, 2. Kyoto Medical Center Clinical Research Center, 3. Doshisha Women's College of Liberal Arts, Department of Pharmacy, Clinical Pharmacy Education and Research Center, 4. Osaka Ohtani University, School of Pharmacy, Clinical Pharmacy Education Center)
[29PB-351]Survey of information on patients with liver dysfunction in the package inserts of prescription drugs compliant with the new instructions
○Rumina Ogiwara1, Tomoya Sakurada1, Nobunori Satoh1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)
[29PA-352]Comparative Assessment of Physical Properties of Transdermal Innovated Aqueous Adhesive System Patch
○Yui Sugiyama1, Tomoya Sakurada1, Nobunori Satoh1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)
[29PB-353]Building generative AI for supportive care prescription
○Manami Oi1, Mayu Suzuki1, Akinori Takagi1, Yutaka Masuda1, Tomoyuki Hamamoto1 (1. Grad. Sch. Pharm. Sci., Showa Pharm. Univ.)
[29PA-354S]Predictivity of the nonclinical toxicity studies on adverse events in the clinical trials of the small molecule new drugs for the central nervous system
○Fumina Karasawa1, Akino Yoshinaga1, Saori Aoki1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm. Sci., IUHW.)
[29PB-355S]Predictivity of the nonclinical toxicity studies on adverse events in the clinical trials of biological drugs
○Akino Yoshinaga1, Fumina Karasawa1, Saori Aoki1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm. Sci., IUHW.)
[29PA-356S]Predictivity of the nonclinical toxicity studies on gastrointestinal adverse events in the clinical trials of the new drugs
○Saori Aoki1, Masaru Saito1, Mizuki Arima1, Fumina Karasawa1, Akino Yoshinaga1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm. Sci., IUHW.)
[29PB-357]Investigation of work efficiency by utilizing generative AI in data management of a large-scale voluntary clinical trial
○Yasue Kawai1, Yoshihiko Ito1, Yuina Nakai1, Motoyasu Miura1, Shinya Uchida1, Takahiro J. Nakamura2, Daisuke Furushima3, Norikata Takuma4, Chika Tagata5, Makoto Kobayashi5, Masami Ichitani5, Hitoshi Kinugasa5, Takanobu Takihara5, Hiroshi Yamada1 (1. Grad. Sch. Pharm. Shi., Univ. of Shizuoka, 2. Sch. Agric., Meiji Univ., 3. Fac. Med., Kagoshima Univ., 4. Hakujujikai, 5. Central Res. Inst., Ito En)
[29PA-358S]A study on the film-forming ability of heparinoid cream formulations: Comparison among formulations and the effect of mixing with white petrolatum
○Niina Shikamura1, Toshiro Fukami2, Tatsuo Koide3, Yoshihisa Yamamoto1 (1. Teikyo Heisei University, 2. Meiji Pharmaceutical University, 3. National Institute of Health Sciences)
[29PA-359S]Effect of mixing with water on the near infrared spectra of heavy magnesium oxide fine granules formulations
○Mayo Mitani1, Toshiro Fukami2, Tatsuo Koide3, Yoshihisa Yamamoto1 (1. Teikyo Heisei University, 2. Meiji Pharmaceutical University, 3. National Institute of Health Sciences)
[29PA-360S]Relationship between the time-course of signal detection index and release of safety information in Japan
○Mia Kimura1, Ryo Inose1, Satoshi Akiba1, Toshiyuki Sakaeda1 (1. Kyoto Pharm. Univ.)
[29PB-361S]Analysis of Factors Contributing to the Occurrence of Psychiatric Adverse Reactions with Montelukast Using Japanese Adverse Drug Event Report database (JADER)
○Mana Miyaura1 (1. Pharm. Kanazawa Univ.)
[29PA-362S]Contributing factors for thrombosis with SERMs using the database of adverse drug reactions.
○Saya Yamauchi1, Takenaka Rina1, Miyaura Mana1, Shibata Yoshihiro1, Arihara Hiroki1, Ishida Natsuko1, Shimada Tsutomu1, Ishizaki Junko1, Matsushita Ryo1, Suga Yukio1 (1. Grad. Sch. Pharm. Sci., Kanazawa Univ.)
[29PA-363S]Efficacy and Safety of Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: A Systematic Review and Meta-Analysis
○Akari Oshima1, Anna Kiyomi1, Kensuke Yoshida1, Munetoshi Sugiura1 (1. Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences)
[29PA-364]Comprehensive analysis of side effects in 71 antidiabetic drugs using AI_SOM: Changes over two years after 2022
○Junko Kawakami1, Marumi Kudo1, Sorama Aoki1, Seiichiro Hayashi2, Kenichi Sato2 (1. Fac. Pharm., Tohoku Med. Pharm. Univ., 2. Cosmos Med. Info. AI Lab.)
[29PA-365S]Development of a Classification Model for Milk to Plasma Concentration Ratios of Drugs Using QSAR Analysis
○Sana Watanabe1, Izumi Ino1, Masahiro Takahashi1, Kazuhiko Hanada1 (1. Meiji Pharm. Univ.)
[29PA-366]Improvement of wireless medication compliance monitoring system
○Kenji Hoshi1, Aoki Sorama1, Kawakami Junko1 (1. Tohoku Medical and Pharmaceutical UNIV.)
[29PB-367]Determination of milk allergens in Japanese polymeric formulae
○Yuma Miyakawa1, Shun Toriumi2, Sayuri Uchiyama3, Yukari Fukushima3, Hirohiko Tairabune6, Kazuto Ohashi1, Shizue Fukawa1, Takeshi Chiba1,4,5, Eisuke Inage2, Hiromichi Shoji2, Toshimi Kimura1,4,5 (1. Department of Pharmacy, Juntendo University Hospital., 2. Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine., 3. Department of Nutrition, Juntendo University Hospital., 4. Center for Clinical Pharmacy Education, Faculty of Pharmacy, Juntendo University., 5. Laboratory of Clinical Pharmacology, Faculty of Pharmacy, Juntendo University., 6. Rejina pharmacy)
[29PA-368]Investigation of the total anticholinergic load of reported anticholinergic drug-related adverse events using the Japanese Adverse Drug Event Report database
○Yusuke Kan1,2,3, Maki Doi2, Yoshihiro Uesawa3 (1. Nanohana Pharmacy, Nanohana Hokkaido., Inc., 2. Department of Academics, Medical System Network., Inc., 3. Department of Medical Molecular Informatics., Meiji Pharmaceutical Univ.)
[29PB-369]The status of generic drug switching toward "selective treatment of long-listed drugs" and challenges for a smooth transition
○Mai Fujimori1, Kumi Narita1, Kunihiko Murooka1, Hisamitsu Takase1 (1. Department of Pharmacy,Juntendo Univ.Urayasu Hospital)
[29PA-370]Attempt to create a drug interaction search tool
○Takahiro Horiuchi1, Hironori Nakamura1 (1. Kitakami Saiseikai Hp.)
[29PA-371S]Current situation and issues of contraindication descriptions for patients with renal impairment in pharmaceutical package Inserts: A survey based on the new Labeling guidelines
○Momo Watanabe1, Masahiro Kobayashi1,2, Tatsuya Okuwaki2, Sumika Nara1, Mika Maeda1,2, Katsuya Otori1,2 (1. Sci. Pharm., Kitasato Univ., 2. Pharm. Dept., Kitasato Univ. Hosp.)
[29PA-372]Prescribing changes after the COVID-19 epidemic readable from NDB open data
○Kayo Machihara1, Shinya Hamada1, Akira Nakatsuma1, Shiho Takagishi1, Yoichi Kawasaki1 (1. Kagawa Sch.Pharm.Sci.,Tokushima Bunri Univ.)
[29PB-373]Qualitative Study on Surrogates’Psychology in Clinical Trial Participation: Decision Making in Medical Emergencies
○Yuko Masamura1, Rieko Takehira1, Etsuko Arita1 (1. Kitasato Univ. Sch. Pharm.)
[29PA-374S]Current situation and challenges of compassionate program (expanded access clinical trials) for medical devices and regenerative medicine products in Japan
○Riko Hirazawa1, Hideki Maeda1 (1. Meiji Pharmaceutical University)
[29PB-375]Research on delirium using the Japanese Adverse Drug Event Report database
○Shuko Iwanaga1, Hideyuki Kushihara1, Shizuha Sakaguchi1, Mitsuki Sato1, Atsuhiko Naruse1 (1. Japanese Red Cross Nagoya Daiichi Hosp.Pharm.)
[29PA-376]Survey on the use of medicines and information sources for pregnant and nursing women in our hospital.
○Shizuha Sakaguchi1, Hideyuki Kushihara1, Mitsuki Sato1, Fusa Yamada1, Tomoe Kushihara1, Chigusa Yamada1, Yuuka Yamamoto1, Atsuhiko Naruse1 (1. Japanese Red Cross Nagoya Daiichi Hosp.Pharm.)